Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ayvakit
Pharma
Sanofi buys Blueprint for $9.1B, its largest deal in 7 years
After signaling its intent to make "bolt-on acquisitions," Sanofi has taken a major plunge, buying out Blueprint Medicines for $9.5 billion.
Kevin Dunleavy
Jun 2, 2025 11:09am
Blueprint art show illustrates life with systemic mastocytosis
Jul 31, 2024 3:10pm
Blueprint boosts Ayvakit peak sales estimate to $2B
Feb 15, 2024 7:00am
Blueprint's Ayvakit picks up long-awaited label expansion
May 22, 2023 4:28pm
Blueprint lays out $1.5B expansion plan for Ayvakit
Feb 17, 2023 10:53am
'Commercial debate' looms over Blueprint's Ayvakit expansion
Aug 17, 2022 11:06am
